Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for February 2010
February 1, 2010
- Basilea Pharmaceutica AG (CH) - Basilea's antifungal isavuconazole passed phase III clinical trial futility analysis
- Breaking News in Emergency Contraception: HRA Pharma Unveils Clinical Data on ellaOne
- Synosia Announces Positive Interim Results for Potential First-in-Class Treatment for Parkinson's Disease
- Positive Results From Phase 1b Study Of Phosphagenics? Transdermal Oxycodone Patch
February 2, 2010
- Soligenix Announces Publication of Positive Stability Results with RiVax, its Vaccine Against Ricin Toxin
- Two Studies Find Artefill to Be a Long-Term Treatment Option for Facial Lipoatrophy
- PROLOR Biotech Reports Positive Top-Line Results From Phase I Study of its Longer-Acting Version of Human Growth Hormone
February 3, 2010
- Transition Therapeutics Announces Results of a Phase 2 Study of TT-223 in Type 2 Diabetes Patients
- Pluristem's PLX Cells May Effectively Treat Ischemic Stroke - Brain Research Journal Reports
- Phosphagenics Announces Positive Results from Phase 1B Study of Transdermal Oxycodone Patch
- Vertex Announces Results from Phase 2a Trial of VX-809 Targeting the Defective Protein Responsible for Cystic Fibrosis
February 4, 2010
- New single dose study shows: Generic extended release nifedipine not bioequivalent to Adalat XL
- The MDS Foundation Says Newly Published Study Finds Vidaza Prolongs Survival in Acute Myeloid Leukemia
February 5, 2010
- BioTime Reports Results from Independent Hextend Study
- BioMarin Reports Encouraging Preliminary Data on BMN 110 for MPS IVA
- New Publication Supports Safety Profile of RECOTHROM Thrombin, Topical (Recombinant) in Numerous Surgical Settings
- Researchers Identify Racial Differences in Pain Treatment Outcomes
- CREON (Pancrelipase) Delayed-Release Capsules Significantly Improves Fat Absorption in Children with Cystic Fibrosis, Study in Clinical Therapeutics Reports
- Protalix Announces Presentation of Phase III Taliglucerase Alfa Data at WORLD Lysosomal Disease Network
- Tanezumab Demonstrated Analgesic Efficacy Across Three Pain Conditions in Phase Two Studies
- Cymbalta Significantly Reduced Chronic Low Back Pain in New Study
- Shire to Present Important Study Findings for Gaucher Disease Treatment and GLD Development Program at the Lysosomal Disease Network (LDN) World Symposium
- LEO Pharma's PEP005 Meets Primary Endpoint in Phase III Trial for Pre-Cancerous Skin Condition
February 8, 2010
- Inovio's Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response
- Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response in Clinical Trial
- Synta Announces STA-9090 Results Demonstrating Potent in vitro and in vivo Activity in AML
- Cara Therapeutics Reports Positive Phase II Data for Novel Peripheral Analgesic in Acute Post-Operative Pain
- Addex Pharmaceuticals (CH) - Addex: ADX71943 Demonstrates Analgesic Effects in Pain Models
- NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults
- Researchers Report Elevated Levels of Tβ4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver Failure
- AMAG Pharmaceuticals Provides Feraheme® Safety Update
February 9, 2010
- Denosumab Demonstrated Superiority Over Zometa in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patients With Bone Metastases
- ThromboGenics - Positive Microplasmin Phase II Data Published in Ophthalmology
- Cerus Corporation Reports Positive Outcome of Phase 1 Clinical Trial of INTERCEPT Red Blood Cells
February 10, 2010
- Mipomersen Phase 3 Study in Patients with Heterozygous Familial Hypercholesterolemia Meets Primary Endpoint
- Curis Publishes CUDC-101 Medicinal Chemistry Data
- PrognosDx Health Announces Publication of Novel Epigenetic Study in Journal of Clinical Oncology
- Amira Pharmaceuticals Announces Efficacy of LPA1 Antagonist in a Preclinical Model of Scleroderma
- Portola Pharmaceuticals Announces Late-Breaker Presentation on Betrixaban at American College of Cardiology's 59th Annual Scientific Session
- Raptor Pharmaceutical Corp. to Present Cystinosis Research at Lysosomal Disease Network's 2010 WORLD Symposium
- American Heart Association Rapid Access Journal Report: Study Finds Racial Gaps Continue in Heart Disease Awareness, Low Knowledge of Heart Attack Warning Signs Among Women
February 11, 2010
- Third Party Reexamination of Javelin Pharmaceuticals' Phase III Trial Data for Ereska (Intranasal Ketamine) Yields Statistically Significant Primary Endpoint
- Two-Year Data from Phase 2 Trial of Genzyme Gaucher Disease Oral Compound Suggest Continued Improvement Across All Endpoints
- Biodel to Present Results from VIAject Phase 3 Studies at Advanced Technologies and Treatments for Diabetes Conference in Basel
- Histone Modification Patterns Predict Prognosis and Treatment Response in Pancreatic Cancer
- Protalix Presents Additional Phase III Data for taliglucerase alfa at the WORLD Symposium
- Intercell obtains results from its first Phase I investigational vaccine study for Streptococcus pneumoniae
February 12, 2010
- Popular antidepressant blocks the beneficial effects of tamoxifen in breast cancer
- Intercell: Phase I data for Pneumococcus vaccine candidate
- Helix BioPharma Announces Positive Interim Results From Its Ongoing Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients With Low-Grade Cervical Lesions
- YM BioSciences Presents CYT387 and CYT997 Data at International Cancer Conference
- Circassia Achieves Positive Phase II Clinical Results With Ragweed Allergy T-Cell Vaccine
- Amicus Therapeutics Presents Positive Data Update From Phase 2 Extension Study of Amigal for Fabry Disease
- Shire Presents Positive Efficacy and Safety Data for velaglucerase alfa in Treatment of Naive Patients With Type 1 Gaucher Disease
February 16, 2010
- Daclizumab Shows Potential For New Immunoregulatory Approach To Treating Multiple Sclerosis, According To Data Published In The Lancet Neurology
- Alkermes Announces Positive Results for Phase 1 Study of New Drug Candidate for Treatment of Opioid-Induced Constipation
- Idera Pharmaceuticals Presents Preclinical Hyperlipidemia Data on a Toll-like Receptor Antagonist at Keystone Symposium
- WHI Study: Short-Term Heart Disease Risks of Combination Hormone Therapy for Postmenopausal Women
- Cannabis Science Announces Preliminary Results of Its Survey of Cannabis Use By Veterans and Others With Post Traumatic Stress Disorder (PTSD) "Listen to What Our Veterans Are Telling Us"
February 17, 2010
- Achillion Announces Positive 96-Week Data for Elvucitabine at the 17th Annual Conference on Retroviruses and Opportunistic Infections
- Pharming?s C1 Inhibitor Product Potentially Effective In Reducing Complications Following Transplantation
- Gardasil Helps Prevent Anal Cancer In Men, Showed New Study
- Migraine More Common in Women with MS
- Leading U.S. Dermatologist Reports Positive Data on Artefill(R)
- In Phase III Data Merck's Gardasil Was Efficacious Against Anal Disease Caused by HPV-6,11,16 and 18
- Statins Increase Risk Of Diabetes, But Absolute Risk Is Low?Especially When Compared With Reduction In Coronary Events
- Gilead's Single-Tablet ?Quad? Regimen for HIV Achieves a High Rate of Virologic Suppression in Phase II Study
- Tobira's Next-Generation Once-Daily CCR5 Receptor Antagonist Demonstrates Efficacy, Safety and Tolerability in Treatment-Experienced Patients With HIV
- CURE Magazine Joins US Oncology
February 18, 2010
- Release: VARI Findings May Help Patients with Deadly Kidney Cancer
- VEGF Trap-Eye Shows Positive Results in a Phase 2 Study in Patients With Diabetic Macular Edema
- New Pain Management Approaches Reduce Pain, Speed Recovery for Knee or Hip Replacement
- GeoVax Labs, Inc. Reports Data on Prototype Adjuvant - Supplemented HIV Vaccine Tested in Preclinical Animal Studies
- BioSante Pharmaceuticals, Inc. to Present LibiGel Clinical Update at ISSWSH Conference
February 19, 2010
- NOVAVAX Presents Positive Clinical Results at The World Health Organization Conference, Geneva, Switzerland
- Preliminary Data from Roche ATHENA Cervical Cancer Trial Support Value of Human Papillomavirus Genotyping
- New Study Compares Efficacy and Safety of Once-Daily Versus Twice-Daily PREZISTA(R) Regimen in Treatment-Experienced Adult Patients With No PREZISTA Mutations
- Pharmacokinetic/Pharmacodynamic Data Support Further Development of Tobira's Next-Generation CCR5 Receptor Antagonist
- VIRxSYS Announces at CROI Promising Results from Its HIV Vaccine Study
February 22, 2010
- Avosentan Reduces Proteinuria but Causes Serious Side Effects
- CEL-SCI Study Shows CEL-2000 Vaccine Blocks Progression of Rheumatoid Arthritis
- Adamas Pharmaceuticals Announces In Vitro Data Demonstrating TCAD Therapy is More Potent Than Double Combinations or Monotherapy Against Drug-Resistant Flu Strains
- Galderma Announces Positive Results Of Study Evaluating A Regimen Of Epiduo Gel And Doxycycline 100mg For Patients With Significant Acne
- BioSante Pharmaceuticals Reports Positive LibiGel Safety Data in Phase III Program - Feb 22, 2010
- MedPage Today and Milwaukee Journal Sentinel Develop Journalism Content Collaboration for Enterprise Medical Reporting
February 23, 2010
- Phase III Study of Avastin Plus Chemotherapy in Advanced Stomach Cancer Did Not Meet Primary Endpoint
- Study Showed Sculptra Aesthetic Effectively Corrects Nasolabial Folds and Other Facial Wrinkles
February 24, 2010
- Publication of Vical's H5N1 Results Paves the Way for H1N1 Clinical Trial
- Data Show Valortim Anthrax Anti-Toxin May Augment Immune System's Ability to Destroy Anthrax Bacteria
- Novelos Therapeutics Pivotal Phase 3 Lung Cancer Trial Does Not Meet the Primary Survival Endpoint
- ANA598 Demonstrates 73% cEVR in Combination With Interferon and Ribavirin
February 25, 2010
- Genentech Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer
- H. Lundbeck A/S (DK) - Data from a post hoc analysis using desmoteplase in ischaemic stroke presented at the International Stroke Conference
- Copaxone 15-Year Study in Multiple Sclerosis Patients Demonstrates Robust Long-Term Efficacy and Safety
February 26, 2010
- Cardiologists Comment on Aspirin Versus Resveratrol
- New Data Demonstrate Early Treatment with a Combination of Enbrel (etanercept) and methotrexate Can Prevent Rheumatoid Arthritis Progression with Sustained Remission at Two Years
- Synta Presents STA-9090 NSCLC Data at the IASLC 10th Annual Targeted Therapies of the Treatment of Lung Cancer Meeting
- Researchers Report Novel Biological Properties of Fragments of Thymosin Beta 4
